ITGR - Earnings call 3 2023 | Integer Holdings Corporation

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Hello, and welcome to the Integer Holdings Corporation Third Quarter 2023 Earnings Call.

[Operator Instructions]

I will now turn the conference over to Mr. Andrew Senn, Senior Vice President, Strategy, Business Development and Investor Relations. Please go ahead.

Andrew Senn

everyone. morning, Good joining XXXX for welcome Integer's to Thank Conference us, Call. Quarter Earnings Third you and With are and and Diron me Executive Smith, Chief today Executive Joe Dziedzic, Vice President Chief Officer. and Financial President Officer;

reminder, the results reflect a discuss periods for consolidated the data of the As we and today the Integer indicated. results

we will call, financial our some non-GAAP measures. During discuss

differ schedules, on earnings For discussion that could appendix factors of the website a refer cause press and Please today's please release to to note reconciliation available for to risk of statements. presentation measures, these company's which the materially. integer.net. actual at includes a our trending presentation, SEC the filings our Please non-GAAP today's are the financial that of today's refer forward-looking results

call, of and provide financial an will news and today's remarks, to will Joe exciting some provide acquisition. and quarter comments call his our closing update then our Joe our year we review share third XXXX for back opening regarding the his open your XXXX come will strategic then guidance. results full will provide the on questions. for Diron will On

I call the to Joe. will that, turn over With

Joseph Dziedzic

you for to and the call joining today. Andrew, you, Thank thank everyone

to premium we partnering is on great as will operational lead that investors. like to leadership forward I Diron congratulate execute for experience deliver as a would and joined our a Integer collaborative brings the to which with and Smith our He with appointed customers, Diron valuation. on our in the role style global excellence candid. is focused being finance to Chief I First, to for manufacturing strong to XXXX Financial Diron enabling earn results CFO strategy our Officer. Diron FP&A business leader. look

to moment greatly X. Mishan, KeyBanc, Before our unexpectedly a I brought and family, remember Integer, to within passed and always sell-side long-time from do to industry. He who we energetic, respected all update September Matt day. our take to was a go Matt thoughtful every our colleagues. what analyst I'd and like away an on humor provide his sense was It hearts missed out of be friends on will

our to our year-over-year Sales of growth organically markets. from results. demand XX% grew another delivered customer strong call. quarter robust Transitioning targeted We earnings across

Our We able points as expanding adjusted to XX% to operating income while well our by to margins improving than expanded gained XXX grew an volume products from our more We margins year. chain. leverage from guidance approximately as supply customers assumed. were deliver prior basis last compared efficiencies

demand, At The customer full sales points we above-market sales market. of raising are outlook growth a to above guidance, grow strategy began to sustain strong the producing continued in at we XXX XX% that XX% XXXX expect year-over-year. year income is on implementing adjusted again. with pipeline year our our and Based we to grow growth operating the full midpoint basis

We growing are of can confident expanding margins income of rate financial operating strategic in at sales the remain XXXX achieve we Xx growth. objective our and

supply the the this and at of It an time achieve labor is execution through demand exciting excellence of because manufacturing further and incredibly chain to strategies expect our stabilization remains direct strong. We environments. Integer

deliver markets, of needed We end including investments concentrated faster-growing products are sustained robust making and have we acquisitions. the new a in tuck-in to pipeline growth,

neurovascular of manufacture of a and strokes portfolio primarily assets industry-leading intracranial aspiration are expertise that developed catheters of used access radial and for They this in in and the the high-growth treatment neurovascular acquisition and a currently portfolio ischemic catheters catheters aneurysms. OEMs. company catheters. design of InNeuroCo capabilities InNeuroCo, of certain manufacturing Earlier we deep completed month, in brings a And the specializing neurovascular

present $X million value plus XXXX. of We price the acquired net The effective purchase specific the benefits is after InNeuroCo million earn-outs targets revenue tax through acquisition potential cash for resulting approximately from $XX considering achieving structure. for lower

existing $XX neurovascular to synergy development expect by InNeuroCo's from XXXX is our team, immediately supporting design and We accretive million catheter of EPS. opportunities. of pipeline sales approximately The transaction

Integer on and markets neurovascular. in this high-growth the are the heart, targets electrophysiology box structural blue that chart, highlighted of Details

of We have high-growth And in capabilities needed serve on to the Integer the markets. for to breadth catheter customers as even faster-growth better outsourcing positioned accelerates, and capitalize these market. depth our demand now neurovascular this is

completely and turn technically are to over or our strategy aspiration neurovascular call markets. to high-growth access catheters our capabilities of and customers InNeuroCo innovative catheters to Neurovascular The enable that radial catheters, differentiated Diron. add now I'll the include solutions strengthen in is guide acquisition aligned catheters. us provide complex with to

Diron Smith

the Joe. on are this our Good to acquisition. includes full I'll our year details an and results financial you for more outlook. again update you, morning, discussion. third It results not thank on provide full everyone, outlook InNeuroCo, important provide today's quarter the while note, Thank XXXX acquisition XXXX year by and of is our third quarter joining impacted

our continued performance. third momentum first half of strong delivering the another We quarter, quarter through

With fluctuations. sales which of an both delivered excludes reported basis, growth sales and a impact year-over-year the on Integer million, $XXX organic XX% of currency

reflects sales customer growth our demand markets performance continued across targeted the improvements chain ongoing and strong environment. Our supply in the the

$XX versus of $XX up We income increased increase million of year. $XX or and last delivered compared million operating year XX%, adjusted to million an prior adjusted or XX% EBITDA, the

our continue we XX.X%, versus of from to efficiencies margin leverage points volume make prior gained the basis adjusted and income percent operating a progress on to by in supply by improvement driven increased year year-over-year the continued As XXX chain. expansion, sales as the

continued compared the and income our of delivered lines we supply deeper will all of or diluted across Vascular in our ago. in on markets, strong C&V to growth touch in structural in third growth quarter share, in by from growth growth new adjusted $X.XX the quarter income such net third heart earnings year-over-year line, and XXXX. adjusted adjusted we strong as year-over-year With guidewires, This sales net in the year key moments. chain product product few demand a XX% Cardio million, I the growth sales improvements. per of Diving up third ramps delivered product by $X.XX a of & $XX double-digit electrophysiology quarter XX% CRM&N products XXXX. was driven and delivered in into

sales and Orthopedics Surgical, by Surgical multiyear Portable customers XX% rhythm emerging the year Cardiac third portable Orthopedics. and of third Advanced in Advanced quarter growth double-digit over the PMA cardiac neuromodulation. management XXXX neuromodulation's and of decline saw and increased a planned growth quarter products in XX% driven management execution both the XXXX improvements. double-digit quarter rhythm with including announced This double-digit exit and was a Medical from chain strong with of demand, supply driven medical by versus third decline and ago, low in in

declined are appendix segment, year normalized rate presentation a our included to And after XX% the lastly, Further from on run ago, product previously higher in at sales line Electrochem, recovery. a chain non-medical returning of supply details from our website the the integer.net.

total minimally Third rate quarter XXXX to exchange improvements XXXX. net quarter related income million offset third of a fluctuations of operational and Strong $XX adjusted by delivered increased sales well the the increase foreign as interest million compared convertible offset interest the higher by expense higher and fixed as rate this issued increased mostly year. interest notes the January million $X lower market-based in were rates the as taxes. benefit of from only interest Year-over-year $XX

XXXX higher higher second in $X ago In flow $XX driver and strong XX-year of XXXX, prior management year to quarter working generated expiration earnings holiday. million we million higher volumes, the adjusted effective of sales a and from the tax primary operations, of $XX from in driven year call, margins described million the by quarter. our This Additionally, capital. was quarter prior improving in Malaysian up than third rate the quarter cash continued tax performance third as our the compared is we the the

$XX In free of generated the flow, $XX expenditures. million cash million capital third inclusive quarter, we of in

from have resulting in in Third flow. generated in of million $XX quarter flow year-to-date, and $XX operations $XXX million cash we CapEx, free invested million cash

well in strategic total third our Net quarter our was total debt by at range. $XX quarter the adjusted EBITDA, debt net trailing leverage within reduced of third our end sequentially, target million X.Xx the X quarter the and

spend our some full outlook for XXXX. updated let's Now the time discussing year

with year our are As our Joe continued raising in strong outlook. full his opening remarks, mentioned XXXX performance, we

inclusive is of InNeuroCo. recent outlook our updated Our acquisition of

we sales, XX% $XX year-over-year an of at with up XX% of increase increasing XX% our XX% with year, of from guidance million to midpoint range sales are $X.XXX to outlook $X.XXX to last billion, a versus Starting growth by to previous XX%. our billion

million growth. Our outlook to XX% from EBITDA adjusted range with guidance $XXX growth XX% $XXX to of up million, our year-over-year of XX% XXXX to for previous a XX% is

be XX% year-over-year million, outlook XXXX adjusted our increasing at to reflecting $XXX expect are and We strong operating between by midpoint of $XX growth to million XX%. and $XXX million a income

expected to our of income to This XX% year-over-year a XX%, of and income from is XX%. year-over-year. operating $X.XX of XX% growth. of At $XXX the a be XX% to delivers expected our of million between net XX% and between EPS adjusted at the growth $X.XX, outlook adjusted an to now previous up sales reflecting million Adjusted rate midpoint growth guidance XX%, growing X.Xx is $XXX

the view adjusted projected and latest Our to tax of effective rate between XX.X% be XX.X%. is

quarter confidence performance given a has percent income to adjusted and which sales again. quarter, strong us after our for see operating sales to of continue raise We as outlook

InNeuroCo million, this outlook Since our $XXX raised by we have for quarter. million year, acquisition guidance the the sales our fourth in midpoint initial at $X including

our increased XX income basis operating guidance full percent expect adjusted and by XXX year-over-year for basis a as have a the now in sales since Additionally, points improvement February we initial our of year. point

an which year capacity from during impact factoring between cash to facilities, includes $XX from receivable $XXX in we average our investments million. $XX We $XXX operations to full expect support of expected shared accounts February manufacturing our call. million flow This approximately to earnings million million

are million sales outlook $XXX of expenditures to initial are $XXX million we guidance, higher on million. XXXX $XXX our maintaining our than capital While

expect Inclusive cash third expect acquisition $XX and million, of million to of million flat our $XX Additionally, debt million to $XXX our quarter we between the of and end is total approximately generate we XXXX. $XX $XXX year-end million. which to from million be flow InNeuroCo, net $XX free XXXX up between

our free in X to leverage to InNeuroCo, We X.Xx expected expect X.X our EBITDA. well net an of trailing offset within cash of quarter the mostly range debt target adjusted resulting fourth at flow quarter ratio year-end, purchase total

call you. the to Thank turn I'll that, With Joe. back

Joseph Dziedzic

year strong sales a is Thanks, and third the last having income XX% X quarters. with including XX%, raising Diron. up guidance quarter operating up adjusted Integer year-to-date

deliver strategy We continue to sustained execute expanding margins. with above-market to growth our

new differentiated products We of a and above-market organically inorganically sustain to growth. pipeline invest in have and strong continue both to capabilities

back call closed they shareholders. our for for serve Thank We our of remain morning. turn for our this acquisition portion in tuck-in to our the delivering accretive and our for premium to you another customers I'll high-growth call. call now valuation on a the focused We Q&A a moderator patients the market. generate joining

Operator

[Operator Instructions]

line comes first Your Bank question from of the Bijou with America. of Craig

Craig Bijou

and Diron, look congrats making working great you on to the permanent, forward a quarter. on congrats role with

to? start the that seen wanted a talked me quarter and very or your upon of in maybe end of to is What you little I existing adds? And So you strong growth customer I you about drivers are let really with new you have by you growth that. the Is it several that some bit if more quarters. the being But markets the over customers know can would the last see utilized guys you end think comments. faster? Are -- do you're expand it attribute growing the

Joseph Dziedzic

things. customers strong you, and that growth, think number do -- or will from we the faster call. will thank with do we is mid-single We growth guided think our There and not us, have we the Craig, growing driving incredibly customers. I'll which industry get to it. do XX% serving. last customers' faster neuromodulation growth things I'd of on results the to had -- our industry the the the rate serve long-term a the up for characterize emerging XX% markets X emerging point shape address our mid-single customers view at I that have I of earlier industry And think stage as we to digit, probably is I'll we midpoint, we which -- X than is of start growing more think for than point we're we is a markets what our as reported doing are digits. of But

-- launch product regulatory phase. and we we've development and them through And phases, about X customers a to $XXX that of X% XXXX, we're growth we're programs, in we year we XXXX, we've our highlighted 'XX have the with depth the so -- out would in this of would couple That's in $XX we that in seeing $XX double, rate And And in clinical growth. introduction set had between that to number million doubling. year last be customers that 'XX expect year. expect are of we that that year-over-year mapped introduction and we of early-stage those growth the next up that 'XX sales to million X% million, a in growth and that in product highlighted by seeing

we're working gone those new the of that we've up over we've the mix been doing, of shifted X of on the how we've that end those number targeting. work that products that development programs in highlighted from that All development we've our XX% years faster-growing a to pipeline percent XXX-plus last has programs of and been markets times be pipeline

introduced into that's of that hundred acquisitions and they we're growth we've neurovascular, electrophysiology, The are Oscor year-over-year done, be a and growth. at accretive heart, points level Structural Integer driving launched couple least products of those marketplace, new the the to basis of seeing Aran, neuromodulation, rate.

order that's magnitude, XXX basis roughly. call So points of it,

our big sometimes multiple in is which guidewires, almost Irish facility all The at industry is it demand. making to feet. demand one, being demand on seeing Guidewire XX,XXX guidewires investment procedures adding because invasive particularly guidewires. take reflected to We're guidewire that's require We're demand square in that on least strong our focused minimally in we're XXX,XXX-plus facility a foot square the in expansion Ireland the business

volume of a year, of the million. and $XX about about that into out XXXX. we have this at end beginning shifted of We million year, 'XX did last That was of to little bit $XX talked

our up We think strong and the we're growing think add you incredibly than get meaningfully in think growing So and for all is points basis these than you XX% things XXX the which we're faster to growth. year, we faster we targeted XXXX. market,

about all targeted across term. of mid-single digit when over above of is. we'll we customers the We widespread we're rate, year we a long-term that think markets long both a in, think outperforming basis the strategy what this of view are serving that strength a by with still I'll they we're end the growth we and the When its the elements market. XXX of have the believe close see But we're think report of executing. have better at our view in number points that growing the we our market markets different We'll our industry reporting

early-stage And space. might market, introducing existing we've working they customers, in your question for Neuromod the won't customers. about new new, the or something emerging particularly existing with of a them I been they're it's -- years customer new to customers and the be to then the say number but

the both the our basis is the and versus we So faster outperformance it's and strength versus industry think targeted widespread, demonstrated XXX than points markets.

Craig Bijou

mainly couple the My OEMs to lot down. second of over be of disruptions last that levels years, the some supply a will eventually chain question, a and worked built inventory traditional protect to than that higher inventory there's thought up against

growth? question I is that So next reaction get but potential to as quarters then to -- look into guess you that just an wanted to out your be a is And risk my process year to several your I that wanted reaction. or get your perspective, just may investor I and I to you thought guess

Joseph Dziedzic

exactly plant, that by see fourth believe we that we level quarter it granular because from customer, don't built we When orders we already So study pretty customers we guidance. by as our a the risk product, at have about a understand by received in billion we're into $X.X good still XX the mostly signal with hand our and in to next of months. to over news The that ship means. on work interpret level, SKU sitting and orders what XX is customers then we

us So that pretty visibility. good gives

by quarter, And we inventory our parts of products, already and of one in year, inventory customers. characterize planning certain we thing they're guidance, into seeing incorporated pre-pandemic we're seeing what businesses because hit year-end a here customers' a fourth that what certain we're because of Every it managing and interpret we level as with our this levels would customers, used level as what we've our they're see pandemic. and might inventory a they which targets we're to to as what normal the before activity, and goals metrics us, for would healthy at signals to got be characterize level and they've is that a doing sign seeing we our good normal do

factored and that guidance, in. our been And into so like built we've that's feel quarter we already fourth

don't And might a about like. so levels would customers inventory concern a potentially correction that see higher be risk meaningful being with of we than a maybe there

Operator

Sandler. line the Piper Your comes from next Matthew of with question O'Brien

Phillip Dantoin

This Congrats Diron, with looking and quarter outstanding the we're I is know on you. forward Phil congrats. on for Matt. working to

on don't how in you disclosed can environment For to growth starters, know the guys. I you I quarter. the price just contributed much if pricing for the

don't want you you at you ability you look just spot, the If beyond. forward this talk specific price, your we durable see and can take to for how I number, and to provide on moving a about putting XXXX as apologize

Joseph Dziedzic

on right quantified to to But sorry, the worries spot. or we in communicated what emphasized standpoint, increases down material. to to we the cost how executing would X% or year very we actually our in and you it we increases we've tell investors both pricing strategy That's some is is and it customers. of It's what increase were That's labor it been I'm experienced we've the it. is specifically we've historically different how I cover our had. this we down have it. putting No cost how to on it's which -- explain very the Typically, positive this From we've a as, it business. positive. us we quantified job X% a than In year-over-year, X% at reason an price price. we're XXXX, year, haven't characterize we're prices raised

price that material expand strategic all pricing. we we ultimately, spirit or with of the in what we've maintain of strong pipeline how and that was customers. our margins objective And ensuring wage cover approach to get done. and enough development hasn't some is that's That's It new and partnership to been to inflation, a product

from neutral-ish forward, meaningful is been forward, agreements going historically. business. going that can manage the a price on basis, in we're believe expect have based change which look-forward we've a we We We place that we where on a

So that's forward. about price how looking we think

Phillip Dantoin

just for I last me. And one quick one guess

interest this how think your impacting you GLP-Xs investor and the term, do category, both all? business in in markets and near at Given of longer of if end some term the

Joseph Dziedzic

Great question. space was medtech trial XX%. announced XX% with early the Well, I'll looks down the in start like it's since August, SELECT to

diabetes think impact we'll customers markets I more believe our an we it we heavily and which are be investor that by So When to negligible. surgery points there's perception. and and that certainly bariatric say been study the impacted GLPs,

In GLPs. And what really at neuromodulation, would show least at structural on and/or heart fact, our -- they based electrophysiology, and has diabetes surgery. customers impacted to when minimally to on focusing thus be appear neurovascular, done, what by appear markets we analysis to to don't growth, drive look they bariatric the been have far anything would we we're support the saying,

growth because markets. of say expect to seeing hearing demand our that Our remains in or targeted are GLPs. demand changing We're us orders or or on customers either they strong not

seeing, call arrhythmias, seeing that seeing order we're I treat and defects, on you the heart that on impact. just demand again, neuromodulation. pain their our management an we're procedures on You're and tell aneurysms, not And structural it's hearing we're -- We're impact. cerebral not earnings that focused can that book

or it's That's working not on the customers not seeing pipeline we're they're and book it's that Maybe impact the development clear. but are But medtech. telling expecting the having valuations impact too on. certainly us order our an any in we're early, of

Operator

question comes Wells from of next the Fargo. line Treybeck Your Nathan with

Nathan Treybeck

great look to with a on Congrats congrats, you. Diron, I quarter working forward and

QX, calculate QX right? reported. about X% your built guide? X% implies light in this QX guidance So through then conservatism growth One, of to of the is just QX there starting in growth is This we And InNeuroCo. the strong into includes --

Joseph Dziedzic

about growth basis. that. So The you're at does midpoint $X that a X% right of million year-over-year InNeuroCo's it imply on

average So splits quarters. quarter it's look XXX basis points the highlight, than of of XX% XXXX, quarter year-over-year. fourth for you at I the higher about 'XX was the X the if first would

fourth thinking got growth. year-over-year we've quarter comps year highest. Year-to-date, just the So about on was a last the XX% basis,

-- strong quarter For we're going the third think the estimating be year. we're midpoint for to XX% We year. incredibly year-to-date, at an that's

I way. we linear for growth in just steady work doesn't but rate year-over-year, exact could like life same every have quarter the that wish everything and

here much pockets environment, -- interpretation. on. you're midpoint a quarter in We've more fourth right we're of that we've and end And disruption supply of the handle got We October. feel so that sitting we're still given on good got the terms the of some pretty stable like working a at chain

we of pretty So very remains good feel sales midpoint the customers. for guidance from demand about strong The XXX-ish our fourth quarter.

as of we high that highlighted what outperformance. the seeing operating and baked We at It's on just the it's fourth quarters, pretty quarter. but fourth year-over-year a the quarter got a strong still customers top that digits. XX% make inventory strong is XX% the feel strong year we're as our for on think I their year-end year normal we and into are Again, we've profit, think X adjustments, first historically line single not

Nathan Treybeck

of the the your just And when to improve. Okay. that inflation has I first you it noted and that to how half? chain environment XXXX. maybe expectations And normalizes supply supply guess in you -- the maybe chain terms so could characterize the relative continued in happen would for

Joseph Dziedzic

Yes. chain. on supply Great question

improvement. meaningful average the quarter chain quarter only was impact So marginally versus third was XQ because better second probably a supply

a of environment are second of the in years second mitigation chain. a was quarter and started into there better environment of are exited and to X.X quarter those but is this and how actions or phase the starting every was think manage better quarter, that We that pockets better day average third still and bring the we're new move So -- supply than execution ago the and we better normal some tougher entered in the and at those about some getting probably benefits. we we

So -- are do we chain. supply at think getting managing we're better we

think operating this supply we're continue improve to forward. chain going going is as We forward, But on the we'll though environment that.

as on labor our From improved sure as turnover in greater with gain into that become direct that is can significant associates grow current a drive we supply supply And chain manufacturing has the move we that chain think to making the our XXXX standpoint, we as proficient in our train expect continue we our to levels efficiencies our that more what facilities we do. well trained as associates execution there's opportunity improving better to efficiencies focus and and margins.

Operator

Instructions] [Operator

question next line from of Citi. Wuensch Joanne Your of the comes

Unknown Analyst

[ for is Philippe Lamar Joanne. This ] on

use forward, you to down? then cash, debt but M&A of forward, InNeuroCo, how pay the as or particularly opportunities? I'm there about as are think it quickly relates curious, that on tuck-in you of And allocation just the segments as think looking thinking congrats are moving about Just M&A are acquisition you any cash attractive

Joseph Dziedzic

our million -- the We're very in start X.Xx the quarter, expected X.X that quarter leverage. acquisition, generation to cash flow at ended fourth to in quarter in outflows and We which remain with fourth debt with, quarter. $XX the the occurred third I'll the X.Xx InNeuroCo committed so fourth we

at gave, at see our year-end, leverage. we you'll look the that to and at the If be expect guidance X.Xx you still EBITDA midpoint the midpoint guidance midpoint debt we at of of levels

a the capacity spend to acquisitions. like year $XXX to have feel we we so $XXX on And tuck-in million million

the at is in a and the transitioning which pipeline We think that in they a tuck-in that historical believe any market we're the of acquisitions in space. have that outsourcing differentiated InNeuroCo. than development We is been we bring point excited more very are time, robust has market, significantly about design we nurturing norm capability neurovascular is very to

So accelerated that's think of outsourcing. a we pocket

that think to And their them, finished and manufacturing and X upon pipeline group business our of that they team then next based tremendous engineering us pipeline designing development to we symbiotically double contributes the very we're accelerate expecting we and that size at in to experience that we think and devices help that think adding the tremendous programs X the has InNeuroCo years and can that developing execute.

order So EBITDA capacity of of of $XXX X.X creates year-end. look think at about continue as where grow at million for year still as sales, way at a $XXX generating $XXX growing million, and free targeted to X.Xx profit is twice magnitude a maybe the debt now debt simple to that's the another worth of X.X fast if $XXX million to rate tuck-in you capacity and acquisitions gives it and at leverage. million $XXX That growth us we that additional we million, million flow get acquisitions, cash every $XXX and capacity maintaining X.X of to

of us So InNeuroCo we're tuck-ins. excited front for additional in about and excited opportunities about the

Unknown Analyst

helpful. That's

you topic, so developing in revenue are those might curious give continues when on a and I'd Just just PSA an if you contribution? hot you can be update us to on where expect meaningful be platforms

Joseph Dziedzic

integrated positioned we're in think well incredibly vertically We Absolutely. today. highly electrophysiology. We're

today device the to everything we're scaling to new we today. CP to finish think We have significant components coming that's manufacturing out. incredibly and do do PFA what products. We experience -- is complex We subassemblies in therapy from applicable

think particular a share a that who what be We're that about both most with for efficacy have market. believe space. has anything think excited will be potential strong comes market and positioned gets share well. tailwind it us. a we're safety new all customer, to for We're for it to excited the as to Like therapy. We're the that positioned to us. of down well tailwind tremendous in who first and in will life, the a wallet but to on it working therapy have we well a we on gets patients, incredibly for market it potentially to impact We the of and programs We're come number

Operator

Instructions] [Operator

are time. this Senn. no back Andrew There further questions at turn call the I will to

Andrew Senn

you, Okay. Thanks, call today. everyone, for joining Sarah. the Thank

we Integer, that as of access can call for you your always, in covered. our presentation interest website replay our on the just this concludes that As call today. well and the Thank you as

Operator

today's for conference joining. concludes Thank call. you This

You disconnect lines. may now your

Integer (ITGR) 26 Oct 232023 Q3 Earnings call transcript